Mid-sized pharma company Glenmark Pharmaceuticals has decided to set up a facility to produce oncology drugs in Buenos Aires in Argentina to strengthen its presence in the global cancer drug market that is expected to grow by nearly 80% to $85 billion in four years.

Marck Biosciences, manufacturer and marketer of sterile dosages pharma products and blow-fill-seal specialist, is planning to enter the Singapore and Malaysian market.

The vaccines landscape is very different now as compared to few years back. With increasing public awareness about preventive healthcare and increased spending by governments for the same has once again put spotlight on the vaccines.

Shire plc, the global specialty biopharmaceutical company, announced a co-promotion agreement with GlaxoSmithKline plc for Vyvanse (lisdexamfetamine dimesylate) capsules CII with the aim of improving recognition and treatment of ADHD in adults.